A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries
Clinical trial NCT05214326 · COMPLETED
Trial details
- NCT number
- NCT05214326
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-18
- Primary completion
- 2023-03-21
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.